Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

New treatments for male hypogonadism are effective and should be personalized.

Oral contraceptives and antiandrogens are effective for treating hirsutism, with antiandrogens being the most effective.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Finasteride causes harmful organ changes in female mice.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Low-dose methotrexate, combined with surgical and local treatments, effectively treats severe vulvovaginal lichen planus.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Metformin helps treat PCOS by improving fertility, reducing symptoms, and regulating periods.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.